Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: tenofovir
Trade Name: Viread
Date Designated: 03/17/2009
Orphan Designation: Treatment of pediatric HIV infection.
Orphan Designation Status: Designated/Approved
Gilead Sciences, Inc.
333 Lakeside Drive
Foster city, California 94404
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: tenofovir
Trade Name: Viread
Marketing Approval Date: 03/24/2010
Approved Labeled Indication: Treatment of HIV infection in combination with other antiretroviral agents in patients 12 to less than 18 years of age
Exclusivity End Date: 03/24/2017 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-